Author/Authors :
Sotirios Tsiodras، نويسنده , , Howard S Gold، نويسنده , , George Sakoulas، نويسنده , , George D. Eliopoulos، نويسنده , , Christine Wennersten، نويسنده , , Lata Venkataraman، نويسنده , , Robert C Moellering Jr، نويسنده , , Mary Jane Ferraro، نويسنده ,
Abstract :
The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various gram-positive bacteria, including meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clinical isolates of S aureus. We have characterised an MRSA isolate resistant to linezolid that was recovered from a patient treated with this agent for dialysis-associated peritonitis.
